Dihexa is a small peptide-derived compound designed to support cognitive function and brain regeneration. It acts by activating the HGF/c-Met signaling pathway, which plays a critical role in forming new synaptic connections and enhancing neuroplasticity. Dihexa also mimics the action of brain-derived neurotrophic factor (BDNF), a key molecule involved in learning, memory, and neuronal survival. Preclinical research studies have shown that Dihexa can significantly improve memory consolidation and reverse cognitive deficits in models of Alzheimer’s disease, traumatic brain injury, and stroke. Unlike traditional nootropics or growth factors with poor blood–brain barrier penetration, Dihexa is orally bioavailable and metabolically stable, allowing for targeted CNS effects. Its unique mechanism positions it as a promising research compound for neurodegenerative conditions, offering potential in synaptic repair, inflammation reduction, and long-term cognitive enhancement.

Epithalon (Epitalon) has long been understood to help preserve telomeres, which are the protective end caps found on fragments of DNA (chromosomes). Telomeres protect DNA from degradation as it is replicated during cell division (one cell splitting into two). Telomeres themselves suffer degradation, however, and eventually become too short to be effective. At this point, a cell will either commit cell suicide in a process called apoptosis or it will go dormant in a process called senescence. Both processes lead to aging and eventual dysfunction and disease. Senescence is one of the primary drivers of disease and aging. Epitalon has been shown to activate an enzyme called telomerase, which protects and repairs telomeres. More active telomerase means that cells age slower and remain functional longer. The net result is that overall aging appears to be slowed down. Research in rodents indicates that Epitalon may extend life by as much as 27% via this mechanism[2], [3]. Epitalon does not only activate telomerase. As noted above, Epitalon has been shown to affect expression for several genes through alteration of DNA structure. This process, called epigenetic modification, is of interest to scientists because it provides the foundation for controlling gene expression at a very fine level. Research is being conducted to learn how to harness epigenetic technology, which could potentially allow scientists to alter everything from an individual’s eye color to how intelligent a person is or how long someone lives. Micro-encapsulated Epitalon has shown excellent orally bioavailability in lab research studies.

Fragment, CJC-1295 (no DAC), and Ipamorelin is a research peptide blend combining hGH Fragment 176–191 with GHRH and ghrelin receptor agonists for coordinated growth hormone axis modeling. The fragment modulates AMPK and β-adrenergic signaling, CJC-1295 (Mod GRF 1–29) activates GHRH receptor pathways, and Ipamorelin stimulates calcium-dependent GHS-R1a signaling. This blend supports research into metabolic peptide synergy and hypothalamic–pituitary function.

Fragment, CJC-1295 (no DAC), and Ipamorelin is a research peptide blend combining hGH Fragment 176–191 with GHRH and ghrelin receptor agonists for coordinated growth hormone axis modeling. The fragment modulates AMPK and β-adrenergic signaling, CJC-1295 (Mod GRF 1–29) activates GHRH receptor pathways, and Ipamorelin stimulates calcium-dependent GHS-R1a signaling. This blend supports research into metabolic peptide synergy and hypothalamic–pituitary function.

GHK-Cu, also known as Copper Tripeptide-1, is a naturally occurring peptide complex formed by the binding of the tripeptide GHK (glycyl-L-histidyl-L-lysine) with a copper ion. It is widely studied in cellular biology due to its role in signaling pathways associated with tissue maintenance and cellular communication.